French biotechs eye U.S. for investment, markets
June 17, 2015 at 11:30 AM EDT
PARIS, June 17 (Reuters) - A group of French biotech companies working in diabetes, cancer and other fields went on the hunt this week for funding and market share in the United States, the world's biggest drugs market.
